• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HbF 促进多态性可能特异性降低伴α-地中海贫血的 SCA 儿童脑血管病的残余风险。

HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.

机构信息

Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie Vasculaire et du Globule Rouge", Université Claude Bernard Lyon 1, COMUE Lyon, France.

Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France.

出版信息

Clin Hemorheol Microcirc. 2021;77(3):267-272. doi: 10.3233/CH-200951.

DOI:10.3233/CH-200951
PMID:33216016
Abstract

Sickle cell anemia (SCA) is a disease characterized by abnormal red blood cell rheology. Because of their effects on HbS polymerization and red blood cell deformability, alpha-thalassemia and the residual HbF level are known genetic modifiers of the disease. The aim of our study was to determine if the number of HbF quantitative trait loci (QTL) would also favor a specific sub-phenotype of SCA as it is the case for alpha-thalassemia. Our results confirmed that alpha-thalassemia protected from cerebral vasculopathy but increased the risk for frequent painful vaso-occlusive crises. We also showed that more HbF-QTL may provide an additional and specific protection against cerebral vasculopathy but only for children with alpha-thalassemia (-α/αα or -α/-α genotypes).

摘要

镰状细胞贫血症 (SCA) 是一种以红细胞流变异常为特征的疾病。由于其对 HbS 聚合和红细胞变形性的影响,α-地中海贫血和残余 HbF 水平是该疾病的已知遗传修饰因子。我们的研究目的是确定 HbF 数量性状基因座 (QTL) 的数量是否也会有利于 SCA 的特定亚表型,就像α-地中海贫血一样。我们的研究结果证实,α-地中海贫血可预防脑血管病,但会增加频繁发生疼痛性血管阻塞危象的风险。我们还表明,更多的 HbF-QTL 可能会为脑血管病提供额外的、特定的保护,但仅限于患有α-地中海贫血的儿童 (-α/αα 或 -α/-α 基因型)。

相似文献

1
HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.HbF 促进多态性可能特异性降低伴α-地中海贫血的 SCA 儿童脑血管病的残余风险。
Clin Hemorheol Microcirc. 2021;77(3):267-272. doi: 10.3233/CH-200951.
2
Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.在塞内加尔接受羟基脲治疗的镰状细胞贫血儿童中,α-地中海贫血和 HbF 数量性状位点的联合和差异效应。
Pediatr Blood Cancer. 2019 Oct;66(10):e27934. doi: 10.1002/pbc.27934. Epub 2019 Jul 19.
3
The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.XmnI (G)γ 多态性影响血红蛋白 F 合成,与 57 例β-地中海贫血中间型患者的 BCL11A 和 HBS1L-MYB SNPs 相反。
Blood Cells Mol Dis. 2010 Aug 15;45(2):124-7. doi: 10.1016/j.bcmd.2010.04.002. Epub 2010 May 15.
4
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.BABY HUG 队列中镰状细胞贫血的遗传修饰物:对实验室和临床表型的影响。
Am J Hematol. 2013 Jul;88(7):571-6. doi: 10.1002/ajh.23457. Epub 2013 May 30.
5
DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.BCL11A、HBS1L-MYB和β-珠蛋白基因座的DNA多态性与镰状细胞病中的胎儿血红蛋白水平和疼痛危象相关。
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11869-74. doi: 10.1073/pnas.0804799105. Epub 2008 Jul 30.
6
Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.BCL11A 和 HBS1L-MYB 基因的功能多态性影响镰状细胞贫血患儿队列的胎儿血红蛋白水平和临床结局。
Ann Hematol. 2020 Jul;99(7):1453-1463. doi: 10.1007/s00277-020-04079-2. Epub 2020 May 23.
7
Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.镰状细胞病的基因修饰因子:马约特岛82名儿童队列中的基因型-表型关系研究
Hemoglobin. 2015;39(3):156-61. doi: 10.3109/03630269.2015.1023897. Epub 2015 Mar 25.
8
Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.BCL11A、HSB1L-MYB 和 XmnI γG-158(C/T)基因多态性与埃及镰状细胞病患者血红蛋白 F 水平的关联。
Ann Hematol. 2020 Oct;99(10):2279-2288. doi: 10.1007/s00277-020-04187-z. Epub 2020 Aug 9.
9
Existence of HbF Enhancer Haplotypes at Intergenic Region in Transfusion-Dependent Saudi -Thalassemia Patients.输血依赖型沙特β地中海贫血患者基因间区域HbF增强子单倍型的存在情况。
Biomed Res Int. 2017;2017:1972429. doi: 10.1155/2017/1972429. Epub 2017 Feb 9.
10
DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.巴西北部镰状细胞贫血患者中,与胎儿血红蛋白水平相关的BCL11A、HBS1L-MYB和Xmn1-HBG2位点的DNA多态性。
Blood Cells Mol Dis. 2014 Dec;53(4):176-9. doi: 10.1016/j.bcmd.2014.07.006. Epub 2014 Jul 30.

引用本文的文献

1
Genetic Modifiers Associated with Vaso-Occlusive Crises and Acute Pain Phenomena in Sickle Cell Disease: A Scoping Review.镰状细胞病中与血管闭塞性危象和急性疼痛现象相关的基因修饰因子:一项范围综述
Int J Mol Sci. 2025 May 7;26(9):4456. doi: 10.3390/ijms26094456.
2
Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease.氧梯度 ektacytometry 衍生的生物标志物与镰状细胞病的急性并发症相关。
Blood Adv. 2024 Jan 23;8(2):276-286. doi: 10.1182/bloodadvances.2023011013.
3
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
遗传变异与镰状细胞病严重程度:系统评价和荟萃分析。
JAMA Netw Open. 2023 Oct 2;6(10):e2337484. doi: 10.1001/jamanetworkopen.2023.37484.